Topic: Lymphoma
Millennium: The Takeda Oncology Company announced the publication of an article in the journal Blood describing the novel mechanism of action of MLN4924 through targeted pathway modulation in diffuse ... moreMillennium: The Takeda Oncology Company announced the publication of an article in the journal Blood describing the novel mechanism of action of MLN4924 through targeted pathway modulation in diffuse ... more
New findings may lead to the development of more effective therapies for inflammation, wounds and malignant tumors LA JOLLA, CA – August 31, 2010 –– In two closely related studies, two teams of Scr ... more
Studies show molecular imaging’s benefits in the evaluation and successful treatment planning for a wide spectrum of diseases Reston, Va.— A series of studies published in the September Journal of N ... more
New studies show that molecular imaging plays a critical role in the evaluation and treatment planning for a broad spectrum of cancers, including thyroid cancer and lymphoma. ... more
September issue highlights, including discussion of a possible association between hepatitis B infection and non-Hodgkin lymphoma in a Korean population. ... more
CD8 T-cell infiltration of the skin in HIV patients can look like lymphoma and was once thought to be malignant - but in fact it's a reactive nonmalignant syndrome that improves when the virus is cont ... more
Viruses that can invade host cells, initiate cancer and then flee from their own trail of destruction could be stopped in their tracks, say researchers writing in the September issue of the Journal of ... more
Ascalon International is a privately held oncology-focused drug development company based in Scottsdale, Arizona. Ascalon was established in June 2009 to create and manage a diversified portfolio of p ... more
Although the use of ovarian tissue cryopreservation and transplantation has lead to 13 live births in women with lymphoma or solid tumors, this method of fertility preservation may be unsafe for patie ... more
Although the use of ovarian tissue cryopreservation and transplantation has lead to 13 live births in women with lymphoma or solid tumors, this method of fertility preservation may be unsafe for patie ... more
Herein is reported the case of a mantle cell lymphoma (MCL) with synchronous double intestinal location. A 74 - year old male presented with mild abdominal pain. CT scan imaging indicated invasion of ... more
Earlier this week, a 23-year-old Omaha man filed a lawsuit claiming that Genentech and Biogen failed to warn of the risks involving the use of their Rituxan immunosupressant -and the subsequent damage ... more
Less chemotherapy and lower radiation doses were effective in early-stage Hodgkin's lymphoma, but long-term questions remain. Medscape Medical News ... more
Breakthrough is the first to push stem cell therapies beyond treatment of blood and marrow disorders University of Minnesota Physician-researchers have demonstrated that a lethal skin disease can be s ... more
Hepatitis B virus, like hepatitis C, is associated with a significant increase in risk for non-Hodgkin's lymphoma. Medscape Medical News ... more
Genmab A/S (OMX: GEN) announced today top-line interim results from an initial Phase II single arm open label study of ofatumumab to evaluate the treatment of relapsed Diffuse Large B-Cell Lymphoma ( ... more
In patients with follicular lymphoma, reduced-intensity T-cell depletion before allogeneic transplantation is an "extremely encouraging strategy" for treating -- and potentially curing -- the disease, ... more
Researchers at UCLA #8217;s Jonsson Comprehensive Cancer Center and the departments of Chemistry and Biochemistry and Pathology and Laboratory Medicine have uncovered a role for an essential cell prot ... more
People infected with hepatitis B virus are around twice as likely to develop non-Hodgkin lymphoma, researchers reported on Tuesday.Source: Reuters Health Related MedlinePlus Pages: Hepatitis B, Lympho ... more
Study finds twice the risk of non-Hodgkin lymphoma ... more
Ben-Gurion University of the Negev (BGU) Professor Varda Shoshan-Barmatz has been awarded a three-year, $600,000 grant from the U.S. Leukemia Lymphoma Society to develop target-specific, anti-cancer ... more
Researchers in Italy have discovered new diagnostic criteria to differentiate peripheral T-cell lymphomas (PTCLs). ... more
Biovest International, Inc. (OTCQB: "BVTI) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BiovaxID®, Biovest's personalized cancer vaccine, for a se ... more
The company is a specialty biopharmaceutical company that utilizes an immunology-based drug development platform to actualize therapeutics indicated for cancer and autoimmune disease. The company €™s ... more
Several Canadian researchers have come together to help control the relentless spread of a prion disease, chronic wasting disease (CWD) in deer and elk, through vaccines. At the same time they aim to ... more
J. Eric Bubbers, PhD, of the Saban Research Institute at Childrens Hospital Los Angeles, has received a $410,000 grant from Phase One Foundation. The award will fund a "first in childhood leukemia" mu ... more
Scott White's Cancer Research Institute (CRI) is conducting a clinical trial that targets malignant T-cell lymphoma, a type of blood cancer. Lymphoma, which affects the white blood cells that normal ... more
#8220;The innovative factor contributed by our work is its relevance to population and measurement of relative survival, which enables us to discover survival related to cancer in a more precise way ... more
Researchers have reported that Rituximab, a drug that is FDA approved to treat B cell lymphoma and rheumatoid arthritis, can also treat severe vasculitis as well as the current standard therapy. Infer ... more
Researchers have reported that Rituximab, a drug that is FDA approved to treat B cell lymphoma and rheumatoid arthritis, can also treat severe vasculitis as well as the current standard therapy. Infer ... more
Researchers have reported that Rituximab, a drug that is FDA approved to treat B cell lymphoma and rheumatoid arthritis, can also treat severe vasculitis as well as the current standard therapy. Infer ... more
Despite hopes that higher blood levels of vitamin D might reduce cancer risk, a large study finds no protective effect against non-Hodgkin lymphoma or cancer of the endometrium, oesophagus, stomach, k ... more
A new study by researchers from the John Theurer Cancer Center at Hackensack University Medical Center sheds light on how bortezomib (VELCADE®), the first in a new class of cancer drugs known as prot ... more
Findings by the John Theurer Cancer Center may lead to more targeted clinical trials and therapies HACKENSACK, N.J. (July 12, 2010) — A new study by researchers from the John Theurer Cancer Center at ... more
A leading UK cancer charity released new figures today that show that people diagnosed with breast, bowel and ovarian cancers, and non-Hodgkin's lymphoma, are today twice as likely to survive at lea ... more
Micromet, Inc. (Nasdaq: MITI) announced the presentation of updated results from a Phase 1 trial of the Company's lead product candidate blinatumomab (MT103) in patients with relapsed non-Hodgkin's ly ... more
CAMBRIDGE, Mass. (July 8, 2010) – Researchers at Whitehead Institute and Children #8217;s Hospital Boston have identified a protein, called Musashi 2, that is predictive of prognosis in acute myeloid ... more
The tunable fluorescent nanoparticles known as quantum dots make ideal tools for distinguishing and identifying rare cancer cells in tissue biopsies, Emory and Georgia Tech scientists have demonstrate ... more
The tunable fluorescent nanoparticles known as quantum dots make ideal tools for distinguishing and identifying rare cancer cells in tissue biopsies. Researchers have learned how multicolor quantum do ... more
In the US, a small clinical trial of RNA-based gene therapy where patients were treated with genetically engineered versions of their own stem cells has shown for the first time that anti-HIV genes c ... more
COLUMBUS, Ohio – Researchers at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) have discovered how a sub ... more
DURHAM, N.C. #8212; An immune cell known to cause chronic inflammation in autoimmune disorders has been identified as a possible culprit in low back pain associated with herniated discs, according to ... more
Cytomegalovirus (CMV) disease is a serious complication after allogeneic hematopoietic stem cell transplantation (allo-SCT), which is widely accepted as a curative therapy for advanced hematological m ... more
Patients with a specific kind of lung cancer may benefit from a Phase III clinical trial offered by the Moores UCSD Cancer Center. The new drug, crizotinib, under development by Pfizer, showed dramati ... more
Many aren't being screened for later cancers, study finds Source: HealthDay Related MedlinePlus Pages: Cancer, Cancer--Living with Cancer, Hodgkin Disease ... more
For the second time within a year, an experimental drug invented by cancer researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove ... more
Prototype drug blocks MCL-1 protein that helps tumors survive treatment BOSTON—Scientists at Dana-Farber Cancer Institute have found a way to disable a common protein that often thwarts chemotherapy ... more
Rome, Italy, Saturday 19 June 2010: For healthcare professionals diagnosing primary Sjögren #8217;s Syndrome (pSS, an autoimmune disorder in which immune cells attack and destroy moisture-producing g ... more
Allos Therapeutics, Inc. (Nasdaq:ALTH) announced that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTC ... more
Allos Therapeutics, Inc. (Nasdaq:ALTH) announced that the European Commission (EC) has granted orphan medicinal product designation for pralatrexate for the treatment of cutaneous T-cell lymphoma (CTC ... more
Many aren't being screened for later cancers, study finds ... more
Despite hopes that higher blood levels of vitamin D might reduce cancer risk, a large study finds no protective effect against non-Hodgkin lymphoma or cancer of the endometrium, esopha ... more
The German Hodgkin Study Group recommends 2 cycles of ABVD followed by 20 Gy involved-field radiotherapy as the new standard of care for early Hodgkin's lymphoma. Medscape Medical News ... more
STANFORD, Calif. #8212; Oncogenes are like friends who #8217;ve gone off the deep end. Normally steady, reliable members of the cellular workforce, these genes become very bad influences when mutated ... more
MMR Information Systems, Inc. (OTCBB: MMRF) announced that a petition has been granted by the U.S. Patent and Trademark Office to reinstate its U.S. Patent titled "Method And Composition For Altering ... more
Visit the new MedlinePlus Health Topic page on cancer and pregnancy.Cancer during pregnancy is rare, but it does happen. The most common cancers in pregnancy are breast cancer, cervical cancer, lymph ... more
Traditional cancer treatments such as chemotherapy have a big drawback: They kill healthy cells as well as malignant ones, producing unpleasant side effects that can range from bothersome to potentia ... more
Contact: Don Powell don@sanger.ac.uk 44-122-349-6928 Wellcome Trust Sanger Institute Reprogramming immune system cells to produce natural killer cells for cancer A team of researchers has developed a ... more
A population-based study of 2,071 Hodgkin lymphoma (HL) survivors over 15 years has discovered that while many survivors had multiple X-rays and CT scans years after treatment was finished, they often ... more
A population-based study of 2,071 Hodgkin lymphoma (HL) survivors over 15 years has discovered that while many survivors had multiple X-rays and CT scans years after treatment was finished, they often ... more
Adult women more prone to the cancer if born to father over 40, study shows Source: HealthDay Related MedlinePlus Pages: Children's Health, Lymphoma ... more
Adult women more prone to the cancer if born to father over 40, study shows ... more
Rituximab has recently been added to the arsenal of treatments for lymphoma patients. Adding rituximab to traditional chemotherapy regimens has been found to increase an individual's chance of cure a ... more
Scripps Research Institute scientists have discovered a new way to target and destroy a type of cancerous cell. The findings may lead to the development of new therapies to treat lymphomas, leukemias, ... more
Contact: Keith McKeown kmckeown@scripps.edu 858-784-8134 Scripps Research Institute The findings open the door to the development of more effective therapies for lymphomas and leukemias LA JOLLA, CA Â ... more
Molecular imaging is leading to more individualized and effective treatment for non-Hodgkin’s lymphoma by providing a map to guide the path of therapy SALT LAKE CITY—According to a study presented a ... more
A Florida State University College of Medicine researcher has discovered a new interaction between a cell signaling system and a specific gene that may be the cause of B-cell lymphoma. The finding sug ... more
A Florida State University College of Medicine researcher has discovered a new interaction between a cell signaling system and a specific gene that may be the cause of B-cell lymphoma. The finding sug ... more
Contact: Doug Carlson doug.carlson@med.fsu.edu 850-645-1255 Florida State University A Florida State University College of Medicine researcher has discovered a new interaction between a cell signaling ... more
Researchers have discovered a new interaction between a cell signaling system and a specific gene that may be the cause of B-cell lymphoma. The finding suggests a similar interaction could be occurrin ... more
Contact: Karl Oestreich newsbureau@mayo.edu 507-284-5005 Mayo Clinic CHICAGO #8212; New research illustrates that some patients with transformed lymphoma showed #8220;remarkable #8221; response to l ... more
New research illustrates that some patients with transformed lymphoma showed "remarkable" response to lenalidomide, an oral drug with few side effects. VIDEO ALERT: Additional audio and video resourc ... more
New research illustrates that some patients with transformed lymphoma showed "remarkable" response to lenalidomide, an oral drug with few side effects. ... more
New results from the PRIMA study show benefits from rituximab maintenance therapy in patients who had responded to rituximab plus chemotherapy for induction. Medscape Medical News ... more
Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced that they have complet ... more
Pre-diagnosis smoking, obesity and alcohol use raise death risk, research shows Source: HealthDay Related MedlinePlus Page: Lymphoma ... more
Two new studies suggest that the prolonged use of cancer drugs helped stunt the progress of the disease, a shift from the scheduled courses of treatment typically delivered to patients, The Wall Stree ... more
Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium: The Takeda Oncology Company today announced that data regarding retreatment experiences with brentuximab vedotin in phase I and phase II clinical ... more
Two new studies suggest that the prolonged use of cancer drugs helped stunt the progress of the disease, a shift from the scheduled courses of treatment typically delivered to patients, The Wall Stre ... more
Pre-diagnosis smoking, obesity and alcohol use raise death risk, research shows ... more
Research also finds Revlimid slows progression of multiple myeloma Source: HealthDay Related MedlinePlus Pages: Lymphoma, Multiple Myeloma ... more
Research also finds Revlimid slows progression of multiple myeloma ... more
Contact: Kevin Punsky punsky.kevin@mayo.edu 904-953-0746 Mayo Clinic JACKSONVILLE, Fla. — Researchers at Mayo Clinic #8217;s campus in Florida have discovered a key gene that, when turned off, promot ... more
Roche announced today data from the Phase III PRIMA study. The data showed that continuing MabThera (rituximab) for two years in patients who responded to initial treatment with MabThera plus chemothe ... more
Three researchers who are recipients of a collaborative grant from the Samuel Waxman Cancer Research Foundation have developed a new type of drug designed to kill non-Hodgkin lymphoma tumor cells. The ... more
PET scans for beneficiaries with lung cancer and lymphoma drove the largest increases. ... more
SRI International, an independent nonprofit research and development organization, announced today that researchers have developed an anti-angiogenic molecule SR16388 that has demonstrated preclinical ... more
Contact: Jenny Song jsong@waxmancancer.org 212-348-0136 Samuel Waxman Cancer Research Foundation Three researchers who are recipients of a collaborative grant from the Samuel Waxman Cancer Research Fo ... more
Eradication of Helicobacter pylori (H. pylori) is a well-accepted initial therapy in cases of localized (stage IE) low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma associated with H ... more
Contact: Ye-Ru Wang wjg@wjgnet.com 86-105-908-0039 World Journal of Gastroenterology Eradication of Helicobacter pylori (H. pylori) is a well-accepted initial therapy in cases of localized (stage … E ... more
A research team from South Korea evaluated the treatment outcome of Helicobacter pylori (H. pylori)-negative low-grade gastric mucosa associated lymphoid tissue (MALT) lymphoma patients to offer thera ... more
In the first study of vitamin K and non-Hodgkin's lymphoma risk, researchers at the Mayo Clinic campus in Minnesota have found that people who have higher intakes of vitamin K from their diet have ... more
In the first study of vitamin K and non-Hodgkin's lymphoma risk, researchers at the Mayo Clinic campus in Minnesota have found that people who have higher intakes of vitamin K from their diet have ... more
Scott White's Cancer Research Institute (CRI) is participating in an international study that targets adult relapsed or refractory B-cell Non-Hodgkin's lymphoma and chronic lymphocytic leukemia. "Th ... more
New research has identified that a key protein called PEA-15 stops T-cell proliferation by blocking the cell's ability to reproduce. The control of T-cell proliferation is essential in preventing cert ... more
One severe complication of celiac disease is enteropathy-associated T cell lymphoma, a high-grade invasive lymphoma with a very poor prognosis. Previous research has suggested that chronic exposure of ... more
Contact: Karen Honey press_releases@the-jci.org 734-546-5242 Journal of Clinical Investigation One severe complication of celiac disease is enteropathy-associated T cell lymphoma, a high-grade invasiv ... more
Researchers from the University of Leeds, UK, the Charite University Medical School and the Max Delbruck Centre for Molecular Medicine (MDC) in Berlin, Germany, have discovered a new driving force beh ... more
Researchers from the University of Leeds, UK, the Charite University Medical School and the Max Delbruck Centre for Molecular Medicine (MDC) in Berlin, Germany, have discovered a new driving force beh ... more
Researchers have discovered a new driving force behind cancer growth. New studies have identified how 'junk' DNA promotes the growth of cancer cells in patients with Hodgkin's lymphoma. ... more
Contact: Paula Gould p.a.gould@leeds.ac.uk 44-113-343-8059 University of Leeds Researchers from the University of Leeds, UK, the Charité University Medical School and the Max Delbrück Centre for Mol ... more
Contact: Karl Oestreich newsbureau@mayo.edu 507-284-5005 Mayo Clinic WASHINGTON — In the first study of vitamin K and Non-Hodgkin lymphoma risk, researchers at the Mayo Clinic campus in Minnesota hav ... more
In the first study of vitamin K and non-Hodgkin's lymphoma risk, researchers have found that people who have higher intakes of vitamin K from their diet have a lower risk of developing non-Hodgkin's l ... more
New data presented at the International Liver CongressTM 2010 found a link between chronic hepatitis B virus (HBV) and progression to cancers other than hepatocellular carcinoma. The study found that ... more
New data presented at the International Liver CongressTM 2010 found a link between chronic hepatitis B virus (HBV) and progression to cancers other than hepatocellular carcinoma. The study found that ... more
Researchers from the Sackler Center at Weill Cornell Medical College have designed a new class of drugs that targets BCL6, a master regulatory protein responsible for causing the most common type of n ... more
Contact: Andrew Klein ank2017@med.cornell.edu 212-821-0560 New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College Experimental compound designed by Weill Cornell re ... more
Scientists are one step closer to developing a targeted therapy for lymphoma. New research identifies a specific small-molecule inhibitor that was nontoxic in animal experiments and could kill human l ... more
Scientists are one step closer to developing a targeted therapy for lymphoma. New research, published by Cell Press in the April 13th issue of the journal Cancer Cell, identifies a specific small-mole ... more
Contact: Dianne Shaw dgs@med.unc.edu 919-966-5905 University of North Carolina School of Medicine Chapel Hill, NC - Important advances in the fight against cancer have come as researchers proved that ... more
A compound that kills specific lymphoma cells has been discovered by an international research team, co-led by the OCI (Ontario Cancer Institute), Canada. This discovery will speed up the development ... more
Contact: Jane Finlayson jane.finlayson@uhn.on.ca 416-946-2846 University Health Network An international research team co-led by the Ontario Cancer Institute (OCI) has discovered a compound that kills ... more
Epoetin alfa is safe and reduces the need for red blood cell (RBC) transfusions during treatment for advanced Hodgkin's lymphoma, researchers report - but it does not improve fatigue and other patient ... more
Contact: Sylvain-Jacques Desjardins sylvain-jacques.desjardins@umontreal.ca 514-343-7593 University of Montreal Promising study published in the Journal of Biological Chemistry This press release is a ... more
Contact: Lauren Woods lauren.woods@nyumc.org 212-404-3753 NYU Langone Medical Center / New York University School of Medicine Study reveals a novel pathway in autoimmune disease By enhancing the activ ... more
Contact: Linda Brooks lbrooks@rsna.org 630-590-7762 Radiological Society of North America OAK BROOK, Ill. A new, large-scale study of more than 10,000 adults found that more than one in every 200 asy ... more
Young adults diagnosed with non-Hodgkin's lymphoma appear to have a higher risk of dying from the disease than do children and teens. ... more
UCSF researchers have discovered that a key cellular defect that disturbs the production of proteins in human cells can lead to cancer susceptibility. The scientists also found that a new generation o ... more
Cells have two different protection programs to safeguard them from getting out of control under stress and from dividing without stopping and developing cancer. Until now, researchers assumed that th ... more
Contact: Elizabeth Fernandez efernandez@pubaff.ucsf.edu 415-476-2557 University of California - San Francisco UCSF researchers have discovered that a key cellular defect that disturbs the production o ... more
Cells have two different protection programs to safeguard them from getting out of control under stress and from dividing without stopping and developing cancer. Now for the first time, using an anima ... more
Seaweed extract may eventually emerge as a lymphoma treatment, according to laboratory research. Seaweeds containing fucoidan, a sulfated polysaccharide similar to heparin in chemical structure, have ... more
A new test that identifies patients with Hodgkin's lymphoma who respond poorly to treatment could revolutionize this field, says expert. Medscape Medical News ... more
Lab study finds extract slows cancer growth without affecting healthy cells ... more
Seaweed extract may eventually emerge as a lymphoma treatment, according to laboratory research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the ... more
Contact: Jeremy Moore jeremy.moore@aacr.org 267-646-0557 American Association for Cancer Research DEAD SEA, Jordan Seaweed extract may eventually emerge as a lymphoma treatment, according to laborato ... more
Contact: Elizabeth Connor eaconnor@ufl.edu 352-273-6387 University of Florida The humble papaya is gaining credibility in Western medicine for anticancer powers that folk cultures have recognized for ... more
Contact: JAMA/Archives Media Relations mediarelations@jama-archives.org 312-464-5262 JAMA and Archives Journals Many important clinical and basic scientific advances have been made in the past five ye ... more
Cell Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) announced that the U.S. Food and Drug Administration's ("FDA") Oncologic Drugs Advisory Committee ("ODAC") will review CTI's New Drug Application ... more
Young adults diagnosed with non-Hodgkin's lymphoma appear to have a higher risk of dying from the disease than do children and teens. Eric Tai, M.D., and colleagues at the Centers for Disease Control ... more
Contact: Jim Ritter jritter@lumc.edu 708-216-2445 Loyola University Health System Bone marrow transplant patients say two of the most debilitating side effects of the treatment are nausea and vomiting ... more
Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemia. PCI-32765 is a new drug being assessed in a Phase I clinical trial at the Virginia G. Pip ... more
Contact: Steve Yozwiak syozwiak@tgen.org 602-343-8704 The Translational Genomics Research Institute PCI-32765 is a new drug being assessed in a Phase I clinical trial at the Virginia G. Piper Cancer C ... more
Cancer researchers have high hopes for a new therapy for patients with certain types of lymphoma and leukemia. ... more
Contact: Karen Kreeger karen.kreeger@uphs.upenn.edu 215-349-5658 University of Pennsylvania School of Medicine PHILADELPHIA - Researchers have found that one particularly aggressive type of blood canc ... more
Contact: Elizabeth Fernandez efernandez@pubaff.ucsf.edu 415-476-2557 University of California - San Francisco Cancer researchers studying the immune system have identified a previously unrecognized se ... more
A new cancer centre, launched today, puts London at the forefront of cancer research. The Barts Cancer Research UK Centre is the latest link in a unique chain of centres being launched around the cou ... more
The Gamida Cell-Teva Joint Venture (JV) announced that the Data Monitoring Committee (DMC) has independently reviewed preliminary data from the pivotal registration, Phase III clinical trial of StemEx ... more
by Kenneth Lin, MD The American Cancer Society has designated this weekend #8220;Suits and Sneakers Awareness Weekend, #8221; as part of the annual Coaches vs. Cancer program that will feature well-d ... more
Earlier this week, shares in Cell Therapeutics plunged when FDA documents revealed serious concerns about the safety and effectiveness of the biotech #8217;s pixantrone med for non-Hodgkin #8217;s lym ... more
Highlights from the Lymphoma Research Foundation (LRF) 2009 Mantle Cell Lymphoma Consortium (MCLC) Scientific Workshop will be published in the March 2010 issue of Leukemia Lymphoma. Traditionally a ... more
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. ... more
Richard I. Fisher, MD - Evaluating Innovative Strategies in Relapsed/Refractory Mantle-Cell Lymphoma
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. ... more
Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information. ... more
Low-dose radiation for Hodgkin's lymphoma leaves children at a significant risk for second malignancies, according to researchers at Stanford University Medical Center in California. Reuters Health ... more
Cancer is a complex disease, and the treatment that helps one patient may do irreparable harm to another. There is a large, unmet need for a diagnostic platform that can look at biopsy samples on a mo ... more
Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35 ... more
Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35 ... more
The proteasome inhibitor bortezomib (Velcade) is effective in patients with follicular lymphoma and other indolent non-Hodgkin's lymphomas, according to a report in the January 12th issue of Clinical ... more
The FDA and Takeda Oncology have notified healthcare professionals that they should reduce the initial dose of bortezomib prescribed for lymphoma patients with moderate-to-severe hepatic impairment. ... more
Contact: Jamie Talan jtalan@nshs.edu 516-562-1232 North Shore-Long Island Jewish (LIJ) Health System Scientists who have identified brain networks damaged in Parkinson #8217;s disease have new evidenc ... more
By Mike Havrilla, ProActive Newsroom Below are some updates and developments from the past week, which I spent in San Francisco for the OneMed, JP Morgan, and other healthcare conferences. I had the o ... more
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced that it has achieved its protocol specified objective of enrolling 100 late-stage patients (Stage IIB to IVA) in its pivotal study for forodesin ... more
Earlier this week, the FDA posted warning letters on its site to four drugmakers - Lilly, Bayer, Amylin Pharmaceuticals and Cephalon - for making inaccurate or incomplete statements while promoting th ... more
Results of a new study in non-small cell lung cancer showed that patients with specific oncogenic rearrangements of the anaplastic lymphoma kinase (ALK) gene within the short arm of chromosome 2 of th ... more
The manufacturer says it is preparing to file for approval on the basis of data that showed an improvement in disease-free survival in lymphoma. Medscape Medical News ... more
Results of a new study in non-small cell lung cancer showed that patients with specific oncogenic rearrangements of the anaplastic lymphoma kinase (ALK) gene within the short arm of chromosome 2 of t ... more
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, today announced the treatment of the first patient in a Phase II study e ... more
4SC AG (Frankfurt, Prime Standard: VSC), a drug discovery and development company focused on autoimmune and cancer indications, today announced the treatment of the first patient in a Phase II study e ... more
Researchers have discovered genetic mutations that may contribute to the development of an aggressive form of non-Hodgkin's lymphoma. These findings provide insight into a mechanism that cancer cells ... more
Although there is a high cure rate and patients make a good recovery, a high level of persistent fatigue is common €” and, for now, unexplained. Medscape Medical News ... more
TetraLogic Pharmaceuticals announced that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, d ... more
TetraLogic Pharmaceuticals announced that the Company has completed dosing of the first cohort in a Phase 1 clinical trial of its selective SMAC mimetic, TL32711. The Phase 1 trial is an open-label, d ... more
Biovest International, Inc. (Other OTC: BVTI) today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to BiovaxID®, Biovest's personalized lymphoma vaccin ... more
Contact: Anne Rueter arueter@umich.edu 734-764-2220 University of Michigan Health System Biomarker will enable doctors to accurately diagnose bone marrow transplant patients #8217; skin rashes and per ... more
Researchers have discovered genetic mutations that may contribute to the development of an aggressive form of non-Hodgkin's lymphoma. These findings provide insight into a mechanism that cancer cells ... more
Researchers have discovered genetic mutations that may contribute to the development of an aggressive form of non-Hodgkin's lymphoma. These findings provide insight into a mechanism that cancer cells ... more
Contact: Andrew Klein ank2017@med.cornell.edu 212-821-0560 New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College Epigenetic diagnosis and therapies, a new strategy ... more
Findings could help those with a type of non-Hodgkin's lymphoma, researchers say Source: HealthDay Related MedlinePlus Topics: Genes and Gene Therapy, Lymphoma ... more
Findings could help those with a type of non-Hodgkin's lymphoma, researchers say ... more
Contact: Katherine Voss kvoss@swmail.sw.org 254-724-4097 Scott White Healthcare Scott White #8217;s Cancer Research Institute (CRI) has launched two clinical trials targeting cancers that affect b ... more
Cancer Research UK and Cancer Research Technology (CRT), the charity's development and commercialisation arm, are to undertake a phase I clinical trial of an investigational monoclonal antibody1 drug ... more
Cancer Research UK and Cancer Research Technology (CRT), the charity's development and commercialisation arm, are to undertake a phase I clinical trial of an investigational monoclonal antibody1 drug ... more
Antibodies directed against the protein CD20, which is expressed by immune cells known as B cells, are used to treat B cell non-Hodgkin lymphoma and rheumatoid arthritis. Despite this, the function of ... more
1. Our reps will wait their turn in medical offices and refrain from waltzing in front of ailing patients because they think their time is more valuable. They will NOT get their own room in medical of ... more
1. Our reps will wait their turn in medical offices and refrain from waltzing in front of ailing patients because they think their time is more valuable. They will NOT get their own room in medical of ... more
UroToday.com - The incidence of testicular cancer (TC) and Hodgkin lymphoma (HL) has increased recently. Although improved chemotherapeutic regimens have augmented survival in men with these malignan ... more
UroToday.com - The incidence of testicular cancer (TC) and Hodgkin lymphoma (HL) has increased recently. Although improved chemotherapeutic regimens have augmented survival in men with these maligna ... more
UroToday.com - The incidence of testicular cancer (TC) and Hodgkin lymphoma (HL) has increased recently. Although improved chemotherapeutic regimens have augmented survival in men with these malignan ... more
UroToday.com - The incidence of testicular cancer (TC) and Hodgkin lymphoma (HL) has increased recently. Although improved chemotherapeutic regimens have augmented survival in men with these maligna ... more
by Dana Griffen Receiving a cancer diagnosis is an upsetting experience for the patient, as well as his or her family and friends. Cancer patients are thrust into a new world with new language and new ... more
Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file. ... more
Richard I. Fisher, MD - Evaluating Innovative Strategies in Relapsed/Refractory Mantle-Cell Lymphoma
Editor David Collingridge discusses highlights from the April issue including: encouraging results from the START trials suggest fewer fractions of radiotherapy could revolutionise treatment of early ... more
"I'm cured, right?" "Yes.""So, why can't I walk?""Well, it's not as simple as that.""The cancer was in my back, right? You said it was in my back? Now, it's not. Now, it's CURED..."It's been 2 mon ... more
Antibodies directed against the protein CD20, which is expressed by immune cells known as B cells, are used to treat B cell non-Hodgkin lymphoma and rheumatoid arthritis. Despite this, the function of ... more
Final results from a large German study show that 2 cycles of chemotherapy and 20 Gy involved-field radiation has the least toxicity while maintaining efficacy. Medscape Medical News ... more
TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial publishe ... more
TWO THIRDS of Hodgkin's lymphoma patients treated with an experimental radioactive cancer therapy responded well to the treatment, reveal the results of a Cancer Research UK phase I trial publishe ... more
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that ... more
Researchers at the Program in Cellular and Molecular Medicine and the Immune Disease Institute at Children's Hospital Boston (PCMM/IDI) have found a link between a common mutation that can lead to can ... more
Supplementation might slow cancer, preliminary study suggests Source: HealthDay Related MedlinePlus Topics: Lymphoma, Vitamins ... more
Allos Therapeutics, Inc. (NASDAQ: ALTH) announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN „¢ (pralatrexate injection) in patients with relapsed or refractory cutaneous T-ce ... more
Allos Therapeutics, Inc. (NASDAQ: ALTH) announced updated data from its ongoing dose finding Phase 1 study of FOLOTYN „¢ (pralatrexate injection) in patients with relapsed or refractory cutaneous T-ce ... more
Seattle Genetics, Inc. (Nasdaq:SGEN) reported data from two phase Ib clinical trials of dacetuzumab, one in combination with Rituxan® (rituximab) and Gemzar® (gemcitabine) for diffuse large B-cell l ... more
Seattle Genetics, Inc. (Nasdaq:SGEN) reported data from two phase Ib clinical trials of dacetuzumab, one in combination with Rituxan® (rituximab) and Gemzar® (gemcitabine) for diffuse large B-cell l ... more
ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, announced the presentation of encouraging initial clinical findings with SAR3419 at the Amer ... more
ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops targeted anticancer therapeutics, announced the presentation of encouraging initial clinical findings with SAR3419 at the Amer ... more
Contact: Rob Graham Rob.Graham@childrens.harvard.edu 617-919-3110 Children #8217;s Hospital Boston Gene enhancer is responsible for activating cancer-causing genes in B cells Researchers at the Progra ... more